REDW logo

Redwood Pharma AB Stock Price

OM:REDW Community·SEK 3.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

REDW Share Price Performance

SEK 0
0.00 (0.00%)
SEK 0
0.00 (0.00%)
Price SEK 0

REDW Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate with adequate balance sheet.

5 Risks
1 Reward

Redwood Pharma AB Key Details

SEK 0

Revenue

SEK 0

Cost of Revenue

SEK 0

Gross Profit

SEK 13.6m

Other Expenses

-SEK 13.6m

Earnings

Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
-5.12
0%
0%
0%
View Full Analysis

About REDW

Founded
2012
Employees
1
CEO
Martin Vidaeus
WebsiteView website
www.redwoodpharma.se

Redwood Pharma AB engages in the development of ophthalmic drugs for medical needs in Sweden. Its lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women; and RP501, a next generation smart hydrogel medical device for the treatment of mild dry eye. The company was founded in 2012 and is headquartered in Stockholm, Sweden.

Recent REDW News & Updates

Recent updates

No updates